Brief: Citius Pharmaceuticals Reports Fiscal Q2 2022 Results
12/05/2022 21:35
May 12 (Reuters) - Citius Pharmaceuticals Inc CTXR.O :
* CITIUS PHARMACEUTICALS, INC. REPORTS FISCAL SECOND QUARTER
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* Q2 LOSS PER SHARE $0.05
* Q2 EARNINGS PER SHARE VIEW $-0.07 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn46fSgca
Further company coverage: CTXR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules